|
1
|
Singh A and Karrar S: The role of
intracellular organisms in the pathogenesis of inflammatory
arthritis. Int J Inflam. 2014:1587932014.PubMed/NCBI
|
|
2
|
Niu XY, Zhang HY, Liu YJ, Zhao D, Shan YX
and Jiang YF: Peripheral B-cell activation and exhaustion markers
in patients with ankylosing spondylitis. Life Sci. 93:687–692.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin Q, Gu JR, Li TW, Zhang FC, Lin ZM,
Liao ZT, Wei QJ, Cao SY and Li L: Value of the peripheral blood
B-cells subsets in patients with ankylosing spondylitis. Chin Med J
(Engl). 122:1784–1789. 2009.PubMed/NCBI
|
|
4
|
Schirmer M, Goldberger C, Würzner R,
Duftner C, Pfeiffer KP, Clausen J, Neumayr G and Falkenbach A:
Circulating cytotoxic CD8(+) CD28(−) T cells in ankylosing
spondylitis. Arthritis Res. 4:71–76. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duftner C, Goldberger C, Falkenbach A,
Würzner R, Falkensammer B, Pfeiffer KP, Maerker-Hermann E and
Schirmer M: Prevalence, clinical relevance and characterization of
circulating cytotoxic CD4+CD28-T cells in ankylosing spondylitis.
Arthritis Res Ther. 5:R292–R300. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smith JA and Colbert RA: Review: The
interleukin-23/interleukin-17 axis in spondyloarthritis
pathogenesis: Th17 and beyond. Arthritis Rheumatol. 66:231–241.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zambrano-Zaragoza JF, Agraz-Cibrian JM,
González-Reyes C, Durán-Avelar Mde J and Vibanco-Pérez N:
Ankylosing spondylitis: From cells to genes. Int J Inflam.
2013:5016532013.PubMed/NCBI
|
|
8
|
Hreggvidsdottir HS, Noordenbos T and
Baeten DL: Inflammatory pathways in spondyloarthritis. Mol Immunol.
57:28–37. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Scarpa R, Costa L, Atteno M, Del Puente A,
Caso F and Moll JM: Psoriatic arthritis: Advances in
pharmacotherapy based on molecular target. Expert Opin
Pharmacother. 14:2311–2313. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fiocco U, Sfriso P, Oliviero F, Lunardi F,
Calabrese F, Scagliori E, Cozzi L, Di Maggio A, Nardacchione R,
Molena B, et al: Blockade of intra-articular TNF in peripheral
spondyloarthritis: Its relevance to clinical scores, quantitative
imaging and synovial fluid and synovial tissue biomarkers. Joint
Bone Spine. 80:165–170. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Toussirot E and Wendling D: Current
guidelines for the drug treatment of ankylosing spondylitis. Drugs.
56:225–240. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sampaio-Barros PD, Costallat LT, Bertolo
MB, Neto JF and Samara AM: Methotrexate in the treatment of
ankylosing spondylitis. Scand J Rheumatol. 29:160–162. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dougados M, Béhier JM, Jolchine I, Calin
A, van der Heijde D, Olivieri I, Zeidler H and Herman H: Efficacy
of celecoxib, a cyclooxygenase 2-specific inhibitor, in the
treatment of ankylosing spondylitis: A six-week controlled study
with comparison against placebo and against a conventional
nonsteroidal antiinflammatory drug. Arthritis Rheum. 44:180–185.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Slobodin G, Rosner I, Rimar D, Boulman N,
Rozenbaum M and Odeh M: Ankylosing spondylitis: Field in progress.
Isr Med Assoc J. 14:763–767. 2012.PubMed/NCBI
|
|
15
|
Farge D, Terriou L, Badoglio M, Cras A,
Desreumaux P, Hadj-Khelifa S, Marjanovic Z, Moisan A, Dulery R,
Faucher C, et al: Autologous stem cell transplantation for
autoimmune diseases: Recommendations from the SFGM-TC. Pathol Biol
(Paris). 62:204–208. 2014.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prevosto C, Zancolli M, Canevali P, Zocchi
MR and Poggi A: Generation of CD4+ or CD8+ regulatory T cells upon
mesenchymal stem cell-lymphocyte interaction. Haematologica.
92:881–888. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Di Ianni M, Del Papa B, De Ioanni M,
Moretti L, Bonifacio E, Cecchini D, Sportoletti P, Falzetti F and
Tabilio A: Mesenchymal cells recruit and regulate T regulatory
cells. Exp Hematol. 36:309–318. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu J, Lin CM, Gu W, Cai XZ, Li Z, Ren MM,
Sun X, Ni J, Shen LJ, Wu W, et al: Immunomodulatory effect of
UC-MSC on function of immunocytes of rats with collagen type II
induced arthritis. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 22:166–170.
2014.(In Chinese). PubMed/NCBI
|
|
19
|
Wang D, Li J, Zhang Y, Zhang M, Chen J, Li
X, Hu X, Jiang S, Shi S and Sun L: Umbilical cord mesenchymal stem
cell transplantation in active and refractory systemic lupus
erythematosus: A multicenter clinical study. Arthritis Res Ther.
16:R792014. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
El-Jawhari JJ, El-Sherbiny YM, Jones EA
and McGonagle D: Mesenchymal stem cells, autoimmunity and
rheumatoid arthritis. QJM. 107:505–514. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kong D, Zhuang X, Wang D, Qu H, Jiang Y,
Li X, Wu W, Xiao J, Liu X, Liu J, et al: Umbilical cord mesenchymal
stem cell transfusion ameliorated hyperglycemia in patients with
type 2 diabetes mellitus. Clin Lab. 60:1969–1976. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van der Linden S, Valkenburg HA and Cats
A: Evaluation of diagnostic criteria for ankylosing spondylitis. A
proposal for modification of the New York criteria. Arthritis
Rheum. 27:361–368. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qu H, Liu X, Ni Y, Jiang Y, Feng X, Xiao
J, Guo Y, Kong D, Li A, Li X, et al: Laminin 411 acts as a potent
inducer of umbilical cord mesenchymal stem cell differentiation
into insulin-producing cells. J Transl Med. 12:1352014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garrett S, Jenkinson T, Kennedy LG,
Whitelock H, Gaisford P and Calin A: A new approach to defining
disease status in ankylosing spondylitis: The bath ankylosing
spondylitis disease activity index. J Rheumatol. 21:2286–2291.
1994.PubMed/NCBI
|
|
25
|
Calin A, Garrett S, Whitelock H, Kennedy
LG, O'Hea J, Mallorie P and Jenkinson T: A new approach to defining
functional ability in ankylosing spondylitis: The development of
the bath ankylosing spondylitis functional index. J Rheumatol.
21:2281–2285. 1994.PubMed/NCBI
|
|
26
|
Jenkinson TR, Mallorie PA, Whitelock HC,
Kennedy LG, Garrett SL and Calin A: Defining spinal mobility in
ankylosing spondylitis (AS). The bath AS metrology index. J
Rheumatol. 21:1694–1698. 1994.PubMed/NCBI
|
|
27
|
Thomas E, Silman AJ, Papageorgiou AC,
Macfarlane GJ and Croft PR: Association between measures of spinal
mobility and low back pain. An analysis of new attenders in primary
care. Spine (Phila Pa 1976). 23:343–347. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
White FA: Physical Signs in Medicine and
Surgery: An Atlas of Rare, Lost and Forgotten Physical Signs.
Museum Press; Ocala, FL: pp. 1772009
|
|
29
|
Anderson JJ, Baron G, van der Heijde D,
Felson DT and Dougados M: Ankylosing spondylitis assessment group
preliminary definition of short-term improvement in ankylosing
spondylitis. Arthritis Rheum. 44:1876–1886. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Daikh DI and Chen PP: Advances in managing
ankylosing spondylitis. F1000Prime Rep. 6:782014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen MH, Chen HA, Chen WS, Chen MH, Tsai
CY and Chou CT: Upregulation of BMP-2 expression in
peripheral-blood mononuclear cells by proinflammatory cytokines and
radiographic progression in ankylosing spondylitis. Mod Rheumatol.
25:913–918. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang X, Lin Z, Wei Q, Jiang Y and Gu J:
Expression of IL-23 and IL-17 and effect of IL-23 on IL-17
production in ankylosing spondylitis. Rheumatol Int. 29:1343–1347.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ji W, Li H, Gao F, Chen Y, Zhong L and
Wang D: Effects of Tripterygium glycosides on interleukin-17 and
CD4+CD25+CD127low regulatory T-cell expression in the peripheral
blood of patients with ankylosing spondylitis. Biomed Rep.
2:517–520. 2014.PubMed/NCBI
|
|
34
|
Lin Q, Gu JR, Li TW, Zhang FC, Lin ZM,
Liao ZT, Wei QJ, Cao SY and Li L: Value of the peripheral blood
B-cells subsets in patients with ankylosing spondylitis. Chin Med J
(Engl). 122:1784–1789. 2009.PubMed/NCBI
|
|
35
|
Wright C, Sibani S, Trudgian D, Fischer R,
Kessler B, LaBaer J and Bowness P: Detection of multiple
autoantibodies in patients with ankylosing spondylitis using
nucleic acid programmable protein arrays. Mol Cell Proteomics.
11:M9.003842012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Doğan SM, Kılınç S, Kebapçı E, Tuğmen C,
Gürkan A, Baran M, Kurtulmuş Y, Olmez M and Karaca C: Mesenchymal
stem cell therapy in patients with small bowel transplantation:
Single center experience. World J Gastroenterol. 20:8215–8220.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ren G, Zhang L, Zhao X, Xu G, Zhang Y,
Roberts AI, Zhao RC and Shi Y: Mesenchymal stem cell-mediated
immunosuppression occurs via concerted action of chemokines and
nitric oxide. Cell Stem Cell. 2:141–150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
De Miguel MP, Fuentes-Julián S,
Blázquez-Martínez A, Pascual CY, Aller MA, Arias J and
Arnalich-Montiel F: Immunosuppressive properties of mesenchymal
stem cells: Advances and applications. Curr Mol Med. 12:574–591.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Bai L, Lennon DP, Eaton V, Maier K, Caplan
AI, Miller SD and Miller RH: Human bone marrow-derived mesenchymal
stem cells induce Th2-polarized immune response and promote
endogenous repair in animal models of multiple sclerosis. Glia.
57:1192–1203. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gao W, Thompson L, Zhou Q, Putheti P,
Fahmy TM, Strom TB and Metcalfe SM: Treg versus Th17 lymphocyte
lineages are cross-regulated by LIF versus IL-6. Cell Cycle.
8:1444–1450. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Awasthi A and Kuchroo VK: Th17 cells: From
precursors to players in inflammation and infection. Int Immunol.
21:489–498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Aggarwal S and Pittenger MF: Human
mesenchymal stem cells modulate allogeneic immune cell responses.
Blood. 105:1815–1822. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Maccario R, Podestà M, Moretta A, Cometa
A, Comoli P, Montagna D, Daudt L, Ibatici A, Piaggio G, Pozzi S, et
al: Interaction of human mesenchymal stem cells with cells involved
in alloantigen-specific immune response favors the differentiation
of CD4+ T-cell subsets expressing a regulatory/suppressive
phenotype. Haematologica. 90:516–525. 2005.PubMed/NCBI
|
|
44
|
Mwale F, Wang HT, Roughley P, Antoniou J
and Haglund L: Link N and mesenchymal stem cells can induce
regeneration of the early degenerate intervertebral disc. Tissue
Eng Part A. 20:2942–2949. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Rafei M, Hsieh J, Fortier S, Li M, Yuan S,
Birman E, Forner K, Boivin MN, Doody K, Tremblay M, et al:
Mesenchymal stromal cell-derived CCL2 suppresses plasma cell
immunoglobulin production via STAT3 inactivation and PAX5
induction. Blood. 112:4991–4998. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Healy ME, Bergin R, Mahon BP and English
K: Mesenchymal stromal cells protect against caspase 3-mediated
apoptosis of CD19(+) peripheral B cells through contact-dependent
upregulation of VEGF. Stem Cells Dev. 24:2391–2402. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tao H, Han Z, Han ZC and Li Z:
Proangiogenic features of mesenchymal stem cells and their
therapeutic applications. Stem Cells Int. 2016:13147092016.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hashemian SJ, Kouhnavard M and
Nasli-Esfahani E: Mesenchymal stem cells: Rising concerns over
their application in treatment of type one diabetes mellitus. J
Diabetes Res. 2015:6751032015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Eom YW, Shim KY and Baik SK: Mesenchymal
stem cell therapy for liver fibrosis. Korean J Intern Med.
30:580–589. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Ham O, Lee CY, Kim R, Lee J, Oh S, Lee MY,
Kim J, Hwang KC, Maeng LS and Chang W: Therapeutic potential of
differentiated mesenchymal stem cells for treatment of
osteoarthritis. Int J Mol Sci. 16:14961–14978. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang C, Wang Y, Meng HY, Yuan XL, Xu XL,
Wang AY, Guo QY, Peng J and Lu SB: Application of bone marrow
mesenchymal stem cells to the treatment of osteonecrosis of the
femoral head. Int J Clin Exp Med. 8:3127–3135. 2015.PubMed/NCBI
|
|
52
|
Asatrian G, Pham D, Hardy WR, James AW and
Peault B: Stem cell technology for bone regeneration: Current
status and potential applications. Stem Cells Cloning. 10:39–48.
2015.
|
|
53
|
Ullah I, Subbarao RB and Rho GJ: Human
mesenchymal stem cells-current trends and future prospective.
Biosci Rep. 35(pii): e001912015.PubMed/NCBI
|
|
54
|
Ng TK, Fortino VR, Pelaez D and Cheung HS:
Progress of mesenchymal stem cell therapy for neural and retinal
diseases. World J Stem Cells. 6:111–119. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Secunda R, Vennila R, Mohanashankar AM,
Rajasundari M, Jeswanth S and Surendran R: Isolation, expansion and
characterisation of mesenchymal stem cells from human bone marrow,
adipose tissue, umbilical cord blood and matrix: A comparative
study. Cytotechnology. 67:793–807. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bieback K, Kern S, Klüter H and Eichler H:
Critical parameters for the isolation of mesenchymal stem cells
from umbilical cord blood. Stem Cells. 22:625–634. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X,
Gong W, Han ZB, Xu ZS, Lu YX, Liu D, et al: Isolation and
characterization of human umbilical cord mesenchymal stem cells
with hematopoiesis-supportive function and other potentials.
Haematologica. 91:1017–1026. 2006.PubMed/NCBI
|
|
58
|
Wang Y, Li Y, Song L, Li Y, Jiang S and
Zhang S: The transplantation of Akt-overexpressing amniotic
fluid-derived mesenchymal stem cells protects the heart against
ischemia-reperfusion injury in rabbits. Mol Med Rep. 14:234–242.
2016.PubMed/NCBI
|
